VISIONEERING TECHNOLOGIES INC. - Announcements

0.00%

6.6¢

Currently unlisted.

Healthcare Medical Devices

Visioneering Technologies, Inc. is an eye care company. The Company designs,... Visioneering Technologies, Inc. is an eye care company. The Company designs, manufactures, sells and distributes contact lenses. The Company provides solutions for presbyopia, myopia and astigmatism. The Company operates through two segments: North America and Europe / Asia-Pacific. The North America segment includes its operations in the United States and Canada. The Europe/Asia-Pacific segment includes its operations outside of North America. The Company’s flagship product is the NaturalVue (etafilcon A) Enhanced Multifocal 1-Day Contact Lens, an extended depth of focus lens for children with myopia (nearsightedness) and adults with presbyopia (the progressive loss of the ability to see near that occurs in middle age). It manages warehousing and distribution of its products through a contract with a third-party logistics provider (3PL). The 3PL stores its inventory and ships it to its customers, which include contact lens distributors.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

VTI	Appendix 4C - quarterly	PRICE SENSITIVE	24/01/19	854.17KB	Share
VTI	Results From Prospective Study in Children	PRICE SENSITIVE	08/11/18	156.63KB	Share
VTI	Appendix 4C - quarterly	PRICE SENSITIVE	12/10/18	879.74KB	Share
VTI	Visioneering Technologies, Inc. Enters European Market	PRICE SENSITIVE	09/10/18	698.49KB	Share
VTI	Notice under ASX Listing Rule 3.10.5A & 7.1A.4	PRICE SENSITIVE	21/08/18	105.74KB	Share
VTI	Appendix 4D & Half-Year Report 30 June 2018	PRICE SENSITIVE	17/08/18	656.58KB	Share
VTI	VTI to raise up to A$11.86 million in placement and SPP	PRICE SENSITIVE	15/08/18	110.79KB	Share
VTI	Trading Halt	PRICE SENSITIVE	13/08/18	309.97KB	Share
VTI	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/18	442.44KB	Share
VTI	Appendix 4C and Cashflow Report Cover Note	PRICE SENSITIVE	13/04/18	418.23KB	Share
VTI	TGA Approval for NaturalVue Lenses	PRICE SENSITIVE	02/03/18	75.48KB	Share
VTI	Appendix 4E Full Year Final Results	PRICE SENSITIVE	27/02/18	1.06MB	Share
VTI	Update - CE Mark for NaturalVue Lenses	PRICE SENSITIVE	01/02/18	600.05KB	Share
VTI	Update - NaturalVue and Paediatric Myopia	PRICE SENSITIVE	29/01/18	74.98KB	Share
VTI	Appendix 4C and Cashflow Report Cover Note	PRICE SENSITIVE	22/01/18	409.02KB	Share
VTI	Update - Multifocal Contact Lenses and Myopia Progression	PRICE SENSITIVE	23/10/17	74.15KB	Share
VTI	Appendix 4C and Cashflow Report Cover Note	PRICE SENSITIVE	18/10/17	444.02KB	Share
VTI	Appendix 4D & Half-Year Report 30 June 2017	PRICE SENSITIVE	29/08/17	464.47KB	Share
VTI	Chinese Patent for Myopia Progression Control Designs	PRICE SENSITIVE	24/08/17	74.32KB	Share
VTI	Appendix 4C and Cashflow Report Cover Note	PRICE SENSITIVE	31/07/17	76.09KB	Share
VTI	Appendix 4C	PRICE SENSITIVE	31/07/17	911.83KB	Share
VTI	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/17	401.21KB	Share
VTI	ASX Market Release - Admission to Official List	PRICE SENSITIVE	27/03/17	242.68KB	Share

VTI Appendix 4C - quarterly
24/01/19	PRICE SENSITIVE	854.17KB	Share
VTI Results From Prospective Study in Children
08/11/18	PRICE SENSITIVE	156.63KB	Share
VTI Appendix 4C - quarterly
12/10/18	PRICE SENSITIVE	879.74KB	Share
VTI Visioneering Technologies, Inc. Enters European Market
09/10/18	PRICE SENSITIVE	698.49KB	Share
VTI Notice under ASX Listing Rule 3.10.5A & 7.1A.4
21/08/18	PRICE SENSITIVE	105.74KB	Share
VTI Appendix 4D & Half-Year Report 30 June 2018
17/08/18	PRICE SENSITIVE	656.58KB	Share
VTI VTI to raise up to A$11.86 million in placement and SPP
15/08/18	PRICE SENSITIVE	110.79KB	Share
VTI Trading Halt
13/08/18	PRICE SENSITIVE	309.97KB	Share
VTI Appendix 4C - quarterly
27/07/18	PRICE SENSITIVE	442.44KB	Share
VTI Appendix 4C and Cashflow Report Cover Note
13/04/18	PRICE SENSITIVE	418.23KB	Share
VTI TGA Approval for NaturalVue Lenses
02/03/18	PRICE SENSITIVE	75.48KB	Share
VTI Appendix 4E Full Year Final Results
27/02/18	PRICE SENSITIVE	1.06MB	Share
VTI Update - CE Mark for NaturalVue Lenses
01/02/18	PRICE SENSITIVE	600.05KB	Share
VTI Update - NaturalVue and Paediatric Myopia
29/01/18	PRICE SENSITIVE	74.98KB	Share
VTI Appendix 4C and Cashflow Report Cover Note
22/01/18	PRICE SENSITIVE	409.02KB	Share
VTI Update - Multifocal Contact Lenses and Myopia Progression
23/10/17	PRICE SENSITIVE	74.15KB	Share
VTI Appendix 4C and Cashflow Report Cover Note
18/10/17	PRICE SENSITIVE	444.02KB	Share
VTI Appendix 4D & Half-Year Report 30 June 2017
29/08/17	PRICE SENSITIVE	464.47KB	Share
VTI Chinese Patent for Myopia Progression Control Designs
24/08/17	PRICE SENSITIVE	74.32KB	Share
VTI Appendix 4C and Cashflow Report Cover Note
31/07/17	PRICE SENSITIVE	76.09KB	Share
VTI Appendix 4C
31/07/17	PRICE SENSITIVE	911.83KB	Share
VTI Appendix 4C - quarterly
28/04/17	PRICE SENSITIVE	401.21KB	Share
VTI ASX Market Release - Admission to Official List
27/03/17	PRICE SENSITIVE	242.68KB	Share

REFRESH

First

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

VISIONEERING TECHNOLOGIES INC. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available